UltraTech Cement, PI Industries, Mazagon Dock Shipbuilders, Gland Pharma, GPT Infraprojects, AU Small Finance Bank, and Interarch Building Products will also be in focus on August 27.
Morgan Stanley Asia (Singapore) Pte bought 1.65 lakh shares (1.24 percent equity) of Repro India, via open market transactions at an average price of Rs 800 per share.
Concord Biotech delivered stellar performance on its debut, rising 27 percent to settle at Rs 942.8 on the NSE, despite weakness in equity markets.